Motif Bio plc Warrants to Purchase ADRs
MTFBW
MTFBW was delisted on the 16th of December, 2019.
3 hedge funds and large institutions have $1.29M invested in Motif Bio plc Warrants to Purchase ADRs in 2017 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and closing their positions.
3% more capital invested
Capital invested by funds: $1.25M → $1.29M (+$40K)
0% more funds holding
Funds holding: 3 → 3 (0)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$2.86K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$20.9K |
MTFBW Hedge Fund Activity: Q1 2017 in Review
3 of the 4,018 institutional investors tracked by Wall St. Rank reported a position in Motif Bio plc Warrants to Purchase ADRs (MTFBW) for Q1 2017, worth a combined $1.29M — up 3.2% from $1.25M a quarter earlier.
Fund positioning in MTFBW was balanced in Q1 2017: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 1 trimmed.
The largest buyer was UBS Group, adding an estimated $2.86K. The largest seller was Sabby Management, cutting an estimated $20.9K.
- 3 institutional investors held Motif Bio plc Warrants to Purchase ADRs (MTFBW) as of Q1 2017, unchanged from Q4 2016.
- Funds reported $1.29M of Motif Bio plc Warrants to Purchase ADRs stock for Q1 2017, up 3.2% quarter-over-quarter.
- 0 funds opened new Motif Bio plc Warrants to Purchase ADRs positions in Q1 2017 and 0 closed out.
- The largest Motif Bio plc Warrants to Purchase ADRs buyer in Q1 2017 was UBS Group, an estimated $2.86K added.
- The largest Motif Bio plc Warrants to Purchase ADRs seller in Q1 2017 was Sabby Management, an estimated $20.9K sold.
Based on aggregated 13F filings for Q1 2017.